Advertisement
 
  Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 27, Issue 11; November 1, 2007

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

Prevention of Tissue Death by Killer Cells?: The Role of the Immune System in Arteriogenesis

Wolfgang Schaper
Arterioscler Thromb Vasc Biol. 2007;27:2273-2274; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.153114
Extract | Full Text | PDF  

 

Brief ReviewsBack

Is Metabolic Syndrome the Main Threat to Human Health in the Twenty-First Century?

Marja-Riitta Taskinen
Arterioscler Thromb Vasc Biol. 2007;27:2275; published online before print September 27 2007, doi:10.1161/ATVBAHA.107.154195
Extract | Full Text | PDF  

Birgit Gustafson, Ann Hammarstedt, Christian X. Andersson, and Ulf Smith
Arterioscler Thromb Vasc Biol. 2007;27:2276-2283; published online before print September 6 2007, doi:10.1161/ATVBAHA.107.147835
Abstract | Full Text | PDF
The Metabolic Syndrome is associated with a dysregulated adipose tissue attributable to inflammation with increased levels of several proinflammatory molecules. This alters the pattern of adipokines produced and prevents the differentiation of preadipocytes. Furthermore, insulin resistance is induced which enhances both lipolysis and the proinflammatory state because insulin has antiinflammatory effects.  

Peter F. Bodary
Arterioscler Thromb Vasc Biol. 2007;27:2284-2291; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.148221
Abstract | Full Text | PDF
Obese individuals have an altered hemostatic profile which favors blood clot formation and thrombosis. To investigate the potential relationship between arterial thrombosis and adipose-derived proteins, mouse models of thrombosis have been used. This review examines the evidence that adipokines have a direct effect on arterial thrombosis.  

Elena Galkina and Klaus Ley
Arterioscler Thromb Vasc Biol. 2007;27:2292-2301; published online before print August 2 2007, doi:10.1161/ATVBAHA.107.149179
Abstract | Full Text | PDF
Leukocyte and endothelial adhesion molecules play key roles in the development and progression of atherosclerosis. In animal models, blocking or eliminating P-selectin, VCAM-1 or {alpha}4β1 integrin reduces atherosclerotic lesion formation by more than 50%. Smaller effects are seen by manipulating E-selectin, ICAM-1 or the JAM family of adhesion molecules.  

Marta Scatena, Lucy Liaw, and Cecilia M. Giachelli
Arterioscler Thromb Vasc Biol. 2007;27:2302-2309; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.144824
Abstract | Full Text | PDF | Data Supplement
Osteopontin OPN is expressed in chronic inflammatory diseases and regulates chemotaxis and cytokine production. Although OPN adhesive domains are characterized, signaling pathways mediating OPN effects on immune cells are not well established. OPN is cleaved by thrombin and matrix-metalloproteases to generate fragments with novel receptor binding sites and activity, suggesting that proteolysis is an important mechanism to regulate OPN function.  

 

Vascular BiologyBack

V. van Weel, R.E.M. Toes, L. Seghers, M.M.L. Deckers, M.R. de Vries, P.H. Eilers, J. Sipkens, A. Schepers, D. Eefting, V.W.M. van Hinsbergh, J.H. van Bockel, and P.H.A. Quax
Arterioscler Thromb Vasc Biol. 2007;27:2310-2318; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.151407
Abstract | Full Text | PDF | Data Supplement
The immune system is thought to play a crucial role in regulating collateral circulation (arteriogenesis). Here, we show that both natural killer cells and CD4+ T-cells modulate arteriogenesis. Promoting lymphocyte activation may represent a promising method to treat ischemic disease.  

Srinivasa Raju Datla, Hitesh Peshavariya, Gregory J. Dusting, Kalyankar Mahadev, Barry J. Goldstein, and Fan Jiang
Arterioscler Thromb Vasc Biol. 2007;27:2319-2324; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.149450
Abstract | Full Text | PDF | Data Supplement
In vitro angiogenic responses were inhibited by Nox4 small interfering RNA or by dominant negative Nox4. Wild-type Nox4 overexpression enhanced VEGF-stimulated signaling, reduced apoptosis, and enhanced the angiogenic responses. Nox4-dependent redox signaling is an important positive modulator of angiogenic responses in human vascular endothelial cells.  

Peter Schroeder, Ruediger Popp, Barbara Wiegand, Joachim Altschmied, and Judith Haendeler
Arterioscler Thromb Vasc Biol. 2007;27:2325-2331; published online before print September 6 2007, doi:10.1161/ATVBAHA.107.149419
Abstract | Full Text | PDF | Data Supplement
Physiological concentrations of ROS and NO activate signaling pathways. ROS induce karyopherin {alpha}-dependent nuclear import of Trx, which is enhanced by posttranslational modifications of Trx. Import of Trx modified antioxidant responsive element containing promoters and increased GST-P1 expression. Knocking down GST-P1 abolished the antiapoptotic properties of ROS. Nuclear Trx plays an important role in endothelial cell apoptosis.  

G.P. van Nieuw Amerongen, C.M.L. Beckers, I.D. Achekar, S. Zeeman, R.J.P. Musters, and V.W.M. van Hinsbergh
Arterioscler Thromb Vasc Biol. 2007;27:2332-2339; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.152322
Abstract | Full Text | PDF | Data Supplement
A well-known effect of activation of Rho kinase by vasoactive agents is disruption of endothelial barrier integrity. Here, we provide evidence for a role of basal Rho kinase activity in regulating proper expression of the junctional adhesion molecule VE-cadherin, opposite to the barrier-disruptive effects of Rho kinase.  

Jennifer Whitsett, Matthew J. Picklo, Sr, and Jeannette Vasquez-Vivar
Arterioscler Thromb Vasc Biol. 2007;27:2340-2347; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.153742
Abstract | Full Text | PDF | Data Supplement
4-Hydroxy-2-nonenal (4-HNE) mediates oxidative stress in the endothelium by controversial mechanisms. This study shows that 4-HNE uncouples eNOS by promoting GTPCH degradation by the proteasome. Sepiapterin and to a lesser extent ascorbate counteracted loss of NO and superoxide increase. Preventing eNOS uncoupling may be important in decreasing 4-HNE cytotoxicity.  

Tibor Fulop, Eva Jebelovszki, Nora Erdei, Tamas Szerafin, Tamas Forster, Istvan Edes, Akos Koller, and Zsolt Bagi
Arterioscler Thromb Vasc Biol. 2007;27:2348-2354; published online before print September 6 2007, doi:10.1161/ATVBAHA.107.147991
Abstract | Full Text | PDF | Data Supplement
The present study shows enhanced dilations of coronary arterioles and brachial arteries in obese hypertensive patients, implying an important functional adaptation, such as an increased sensitivity to NO of coronary and peripheral arterial vessels, to the simultaneous presence of obesity and hypertension.  

Xiangbin Xu, Chang-Hoon Ha, Chelsea Wong, Weiye Wang, Angelika Hausser, Klaus Pfizenmaier, Eric N. Olson, Timothy A. McKinsey, and Zheng-Gen Jin
Arterioscler Thromb Vasc Biol. 2007;27:2355-2362; published online before print September 6 2007, doi:10.1161/ATVBAHA.107.151704
Abstract | Full Text | PDF | Data Supplement
Angiotensin II is implicated in the pathological vascular remodeling. In this study we demonstrate a critical role of protein kinase D and histone deacetylases 5 in Angiotensin II-induced VSMC hypertrophy, and reveal a new signal pathway for the pathological vascular effects of Angiotensin II.  

Takaaki Yamada, Takahisa Kondo, Yasushi Numaguchi, Michitaka Tsuzuki, Tatsuaki Matsubara, Ichiro Manabe, Masataka Sata, Ryozo Nagai, and Toyoaki Murohara
Arterioscler Thromb Vasc Biol. 2007;27:2363-2369; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.147124
Abstract | Full Text | PDF | Data Supplement
Bone marrow (BM)-derived cells differentiate into smooth muscle-like cells at injured arteries and contribute to neointimal formation. However, role of angiotensin II (ATII) in this process was unknown. Here we show that ATII accelerated whereas AT1 receptor blocker (ARB) suppressed this process. These are new aspects of ARB-mediated inhibition of atherosclerotic disease.  

Yafa Naim Abu Nabah, Mercedes Losada, Rossana Estellés, Teresa Mateo, Chantal Company, Laura Piqueras, Concha Lopez-Gines, Henry Sarau, Julio Cortijo, Esteban J. Morcillo, Peter J. Jose, and Maria-Jesus Sanz
Arterioscler Thromb Vasc Biol. 2007;27:2370-2376; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.147009
Abstract | Full Text | PDF | Data Supplement
The effect of a CXCR2 antagonist, SB-517785-M, on angiotensin-II (Ang-II) vascular inflammation was investigated. SB-517785-M reduced Ang-II-induced release of CC chemokines, arteriolar adhesion, and recruitment of mononuclear cells in rats. Therefore CXCR2 antagonists may help to prevent mononuclear cell infiltration and the progression of the atherogenic process.  

Roberta De Mori, Stefania Straino, Anna Di Carlo, Antonella Mangoni, Giulio Pompilio, Roberta Palumbo, Marco E. Bianchi, Maurizio C. Capogrossi, and Antonia Germani
Arterioscler Thromb Vasc Biol. 2007;27:2377-2383; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.153429
Abstract | Full Text | PDF | Data Supplement
In this study we provide evidence of the involvement of HMGB1 in skeletal muscle regeneration. Endogenous HMGB1 blockade or HMGB1 administration, in a mouse model of hindlimb ischemia, affect myoblast function and neovascularization. HMGB1 induces myoblast migration and modulates endothelial cell functions in vitro, activating JNK and ERK signaling pathways.  

 

Atherosclerosis and LipoproteinsBack

Masakazu Shinohara, Ken-ichi Hirata, Tomoya Yamashita, Tomofumi Takaya, Naoto Sasaki, Rio Shiraki, Tomomi Ueyama, Noriaki Emoto, Nobutaka Inoue, Mitsuhiro Yokoyama, and Seinosuke Kawashima
Arterioscler Thromb Vasc Biol. 2007;27:2384-2391; published online before print September 13 2007, doi:10.1161/ATVBAHA.106.139253
Abstract | Full Text | PDF | Data Supplement
Local cotransfection of TLR2 and TLR4 at the vessel wall synergistically accelerated atherosclerosis in carotid arteries of rabbits fed a high-cholesterol diet. The synergistic augmentation was likely related to the marked activation of NF-{kappa}B, leading to augmented expressions of ICAM-1, VCAM-1, and MCP-1, at the vessel wall.  

Roland Klingenberg, Jerzy-Roch Nofer, Mats Rudling, Florian Bea, Erwin Blessing, Michael Preusch, Hermann J. Grone, Hugo A. Katus, Göran K. Hansson, and Thomas J. Dengler
Arterioscler Thromb Vasc Biol. 2007;27:2392-2399; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.149476
Abstract | Full Text | PDF | Data Supplement
Administration of the sphingolipid analogue FTY720 to ApoE-/- mice on normal laboratory diet altered lipid metabolism yielding pronounced hypercholesterolemia. Despite lymphocyte depletion and retrafficking the overall balance of pro- and antiatherogenic lymphocyte populations was not changed. Hypercholesterolemia appears to have counteracted the otherwise beneficial effect on atherogenesis.  

Yukio Fujiwara, Naoko Kiyota, Masaharu Hori, Sayaka Matsushita, Yoko Iijima, Koh Aoki, Daisuke Shibata, Motohiro Takeya, Tsuyoshi Ikeda, Toshihiro Nohara, and Ryoji Nagai
Arterioscler Thromb Vasc Biol. 2007;27:2400-2406; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.147405
Abstract | Full Text | PDF | Data Supplement
Esculeogenin A, a new aglycon of esculeoside A isolated from tomato, significantly inhibited the accumulation of cholesterol ester in macrophages by inhibiting acyl-CoA: cholesterol acyl-transferase (ACAT). Oral administration of esculeoside A to apoE-deficient mice significantly reduced the levels of serum cholesterol and the areas of atherosclerotic lesions.  

Nicolas Ogier, Alexis Klein, Valérie Deckert, Anne Athias, Ginette Bessède, Naig Le Guern, Laurent Lagrost, and Catherine Desrumaux
Arterioscler Thromb Vasc Biol. 2007;27:2407-2412; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.151753
Abstract | Full Text | PDF | Data Supplement
Although systemic PLTP is proatherogenic, recent findings suggested that macrophage-derived PLTP could be antiatherogenic. This study shows that the reduced {alpha}-tocopherol content of isolated macrophages from PLTP-deficient mice is associated with increased cholesterol accumulation in these cells. Cholesterol parameters in the macrophages of PLTP-deficient mice were normalized by dietary supplementation with {alpha}-tocopherol.  

Miranda Van Eck, Menno Hoekstra, Reeni B. Hildebrand, Yuemang Yaong, Dominique Stengel, J. Kar Kruijt, Wolfgang Sattler, Uwe J.F. Tietge, Ewa Ninio, Theo J.C. Van Berkel, and Domenico Praticò
Arterioscler Thromb Vasc Biol. 2007;27:2413-2419; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.145474
Abstract | Full Text | PDF | Data Supplement
HDL reduces atherosclerosis by its antioxidant properties. In the current study we show that disruption of SR-BI, a prominent regulator of HDL metabolism, decreases the activity of the HDL-associated antioxidant enzyme paraoxonase 1 and leads to increased oxidative stress, potentially contributing to the proatherogenic effect of SR-BI deficiency.  

Laeticia Lichtenstein, Jimmy F.P. Berbée, Susan J. van Dijk, Ko Willems van Dijk, André Bensadoun, Ido P. Kema, Peter J. Voshol, Michael Müller, Patrick C.N. Rensen, and Sander Kersten
Arterioscler Thromb Vasc Biol. 2007;27:2420-2427; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.151894
Abstract | Full Text | PDF | Data Supplement
The present study exploits the fasting-dependent phenotype of Angptl4-transgenic mice to characterize the function of Angptl4. We conclude that: (1) Angptl4 causes hypertriglyceridemia by inhibiting LPL-dependent VLDL lipolysis by converting LPL dimers to monomers, and (2) Angptl4 upregulates hepatic cholesterol synthesis secondary to inhibition of LPL- and HL-dependent hepatic cholesterol uptake.  

Shucun Qin, Tianjiao Liu, Vaijinath S. Kamanna, and Moti L. Kashyap
Arterioscler Thromb Vasc Biol. 2007;27:2428-2434; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.150193
Abstract | Full Text | PDF
This study examined the mechanism by which pioglitazone increases apoA-I/A-II and HDL. Pioglitazone, by PPAR-{alpha}-mediated events increased the synthesis of apoA-I and apoA-II without affecting the uptake of HDL. Hepatic activation of PPAR-{alpha} may be involved in the effect of pioglitazone to raise apoA-I and HDL.  

Abhijit Dandapat, Changping Hu, Liuqin Sun, and Jawahar L. Mehta
Arterioscler Thromb Vasc Biol. 2007;27:2435-2442; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.152272
Abstract | Full Text | PDF | Data Supplement
Low levels of reactive oxygen species function as signaling molecules for angiogenesis. In keeping with this concept, we postulated and found that oxLDL (0.1 to 5 {micro}g/mL) promoted capillary tube formation by inducing the expression of VEGF via LOX-1-mediated activation of NADPH oxidase-MAPKs-NF-{kappa}B pathway.  

Mary Y.K. Lee, Hung-Fat Tse, Chung-Wah Siu, Shu-Guang Zhu, Ricky Y.K. Man, and Paul M. Vanhoutte
Arterioscler Thromb Vasc Biol. 2007;27:2443-2449, doi:10.1161/ATVBAHA.107.141705
Abstract | Full Text | PDF | Data Supplement
Genomic changes were determined in cultured regenerated endothelial cells. cGMP production was reduced. Changes in mRNA expression related to vasomotor control, coagulation, oxidative stress, extracellular matrix, and lipid were confirmed by Western blotting for eNOS, F2, Mn SOD, matrix metalloproteinase 7, and TR. These findings reveal linkages between regeneration and endothelial dysfunction.  

Jian Wang, Henian Cao, Matthew R. Ban, Brooke A. Kennedy, Siqi Zhu, Sonia Anand, Salim Yusuf, Rebecca L. Pollex, and Robert A. Hegele
Arterioscler Thromb Vasc Biol. 2007;27:2450-2455; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.150680
Abstract | Full Text | PDF
Severe hypertriglyceridemia has been presumed to have a genetic basis, but this has never been quantified. With resequencing, we now document a range of DNA variants in LPL, APOC2, and APOA5 genes which together were found in 41.8% of patients with severe HTG compared with 8.9% of control subjects (P<10-13).  

Tomoya Mita, Hirotaka Watada, Tomoaki Shimizu, Yoshifumi Tamura, Fumihiko Sato, Takahiro Watanabe, Jong Bock Choi, Takahisa Hirose, Yasushi Tanaka, and Ryuzo Kawamori
Arterioscler Thromb Vasc Biol. 2007;27:2456-2462; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.152835
Abstract | Full Text | PDF | Data Supplement
To investigate the effect of nateglinide on atherosclerosis, we performed an open labeled randomized prospective trial on drug-naive type 2 diabetic patients whose HbA1c was less than 6.5%. The carotid intima-media thickness at the end of 1-year follow-up period was significantly decreased in the nateglinide group compared with the untreated group. In type 2 diabetic patients under good glycemic control, further strict glycemic control by nateglinide results in regression of carotid intima-media thickness.  

Marc S. Sabatine, David A. Morrow, Michelle O’Donoghue, Kathleen A. Jablonksi, Madeline Murguia Rice, Scott Solomon, Yves Rosenberg, Michael J. Domanski, Judith Hsia for the PEACE Investigators
Arterioscler Thromb Vasc Biol. 2007;27:2463-2469; published online before print August 31 2007, doi:10.1161/ATVBAHA.107.151670
Abstract | Full Text | PDF
In 3766 patients with stable CAD, an elevated level of Lp-PLA2 was a significant predictor of adverse cardiovascular outcomes independent of traditional clinical risk factors. When analyzed together, both hs-CRP and Lp-PLA2 were highly significant predictors of ACS, whereas only Lp-PLA2 was a significant predictor of revascularization.  

 

ThrombosisBack

Li Zhang, Zheng Gang Zhang, Xian Shuang Liu, Ann Hozeska-Solgot, and Michael Chopp
Arterioscler Thromb Vasc Biol. 2007;27:2470-2475; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.150748
Abstract | Full Text | PDF
Combination treatment with atorvastatin and tPA 4h after embolic stroke substantially reduced infarct volume and activated Akt. Blockage of the PI3K/Akt pathway with wortmannin completely abolished the neuroprotective effect of the combination therapy. These data indicate that the PI3K/Akt pathway mediates the neuroprotective effects of atorvastatin.  

Suzanne J.A. Korporaal, Miranda Van Eck, Jelle Adelmeijer, Martin Ijsseldijk, Ruud Out, Ton Lisman, Peter J. Lenting, Theo J.C. Van Berkel, and Jan-Willem N. Akkerman
Arterioscler Thromb Vasc Biol. 2007;27:2476-2483; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.150698
Abstract | Full Text | PDF | Data Supplement
Platelets are activated by nLDL through binding to apoER2', which signals to p38MAPK. Oxidation induces more p38MAPK activation through loss of apoER2' binding thereby initiating the combined activity of CD36 and SR-A.  

Imke C.A. Munnix, Marijke J.E. Kuijpers, Jocelyn Auger, Christella M.L.G.D. Thomassen, Peter Panizzi, Marc A.M. van Zandvoort, Jan Rosing, Paul E. Bock, Steve P. Watson, and Johan W.M. Heemskerk
Arterioscler Thromb Vasc Biol. 2007;27:2484-2490; published online before print August 30 2007, doi:10.1161/ATVBAHA.107.151100
Abstract | Full Text | PDF | Data Supplement
The organization and integration of 2 key functions of platelets, aggregation and procoagulant activity, is investigated. During thrombus formation under flow, platelets in aggregates segregate from patches of coagulation-active platelets with low integrin activation. The inactivation of integrins in procoagulant platelets is triggered by tyrosine kinase activity.  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage